The Safety of Digital Mental Health Interventions: Systematic Review and Recommendations
JMIR Mental Health · 09.10.2023 · 10 · e47433
DOI: 10.2196/47433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JMIR Mental Health, online erschienen am 09.10.2023. Verfasst von Rayan Taher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Psychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, United Kingdom. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Background
Evidence suggests that digital mental health interventions (DMHIs) for common mental health conditions are effective. However, digital interventions, such as face-to-face therapies, pose risks to patients. A safe intervention is considered one in which the measured benefits outweigh the identified and mitigated risks.
Objective
This study aims to review the literature to assess how DMHIs assess safety, what risks are reported, and how they are mitigated in both the research and postmarket phases and building on existing recommendations for assessing, reporting, and mitigating safety in the DMHI and standardizing practice.
Methods
PsycINFO, Embase, and MEDLINE databases were searched for studies that addressed the safety of DMHIs. The inclusion criteria were any study that addressed the safety of a clinical DMHI, even if not as a main outcome, in an adult population, and in English. As the outcome data were mainly qualitative in nature, a meta-analysis was not possible, and qualitative analysis was used to collate the results. Quantitative results were synthesized in the form of tables and percentages. To illustrate the use of a single common safety metric across studies, we calculated odds ratios and CIs, wherever possible.
Results
Overall, 23 studies were included in this review. Although many of the included studies assessed safety by actively collecting adverse event (AE) data, over one-third (8/23, 35%) did not assess or collect any safety data. The methods and frequency of safety data collection varied widely, and very few studies have performed formal statistical analyses. The main treatment-related reported AE was symptom deterioration. The main method used to mitigate risk was exclusion of high-risk groups. A secondary web-based search found that 6 DMHIs were available for users or patients to use (postmarket phase), all of which used indications and contraindications to mitigate risk, although there was no evidence of ongoing safety review.
Conclusions
The findings of this review show the need for a standardized classification of AEs, a standardized method for assessing AEs to statically analyze AE data, and evidence-based practices for mitigating risk in DMHIs, both in the research and postmarket phases. This review produced 7 specific, measurable, and achievable recommendations with the potential to have an immediate impact on the field, which were implemented across ongoing and future research. Improving the quality of DMHI safety data will allow meaningful assessment of the safety of DMHIs and confidence in whether the benefits of a new DMHI outweigh its risks. Trial Registration PROSPERO CRD42022333181; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=333181
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Psychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, United Kingdom.
- Department of Psychology, University of Bath, Bath, United Kingdom.
- London Institute for Healthcare Engineering, King's College London, London, United Kingdom.
- Kent and Medway Medical School, Canterbury, Kent, United Kingdom.
ORCID-Profile: Rayan Taher, Che-Wei Hsu, Chloe Hampshire, Carolina Fialho, Clare Heaysman, Daniel Stahl, Sukhi Shergill, Jenny Yiend
Förderung
- Medical Research Council
Zitieren
APA
Taher, R., Hsu, C. W., Hampshire, C., Fialho, C., Heaysman, C., Stahl, D., Shergill, S., & Yiend, J. (2023). The Safety of Digital Mental Health Interventions: Systematic Review and Recommendations. JMIR Mental Health, 10, e47433. https://doi.org/10.2196/47433
Vancouver
Taher R, Hsu CW, Hampshire C, Fialho C, Heaysman C, Stahl D, et al. The Safety of Digital Mental Health Interventions: Systematic Review and Recommendations. JMIR Mental Health. 2023;10:e47433. doi:10.2196/47433
BibTeX
@article{Taher2023,
author = {Taher, Rayan and Hsu, Che-Wei and Hampshire, Chloe and Fialho, Carolina and Heaysman, Clare and Stahl, Daniel and Shergill, Sukhi and Yiend, Jenny},
title = {The Safety of Digital Mental Health Interventions: Systematic Review and Recommendations},
journal = {JMIR Mental Health},
year = {2023},
volume = {10},
pages = {e47433},
doi = {10.2196/47433}
}
EUVIMED